Roundup: BJS to Study Teens Transferred into Adult Justice System -- and More
By Benjamin Chambers, November 12 2010
-
How many youth are transferred from the juvenile justice system into the adult criminal justice system every year? No one knows. But the Bureau of Justice Statistics is initiating a study that should get us get closer to an answer to this an other questions about adult transfer practices. (Hat tip to Youth Today.) - End the Byrne JAG formula grants? That's one of the Justice Policy Institute's (JPI) recommendations in a recent fact sheet on Byrne Justice Assistance Grant (JAG) Program spending. (JPI recommends replacing the formula grants with a competitive grant program focused on evidence-based programming.)
The JPI also recommended that juvenile justice funds be directed at "educational and community-based youth programming" and that substance abuse and mental health treatment services be funded through public health agencies, and not through the justice system: "By reaching people before they come in contact with the justice system, we can reduce future justice involvement and related costs, and reduce the chances that someone will have to deal with the collateral consequences of having a criminal record."




Juvenile Justice News
Once upon a time, in the 1990s, Ecstasy was a rave drug, surrounded by whirling glow-sticks and teenagers looking for a good time. When organizations like the Foundation for a Drug-Free World started spreading the word about Ecstasy’s hazards via public service announcements, the drug began to go out of style. As with most drugs, education is prevention. Today, the general population is well aware that users of Ecstasy, also known as MDMA, are at a high risk for dangerous side effects such as mental trauma, memory loss, seizure, stroke, and kidney failure. Dr. Caitlin Reed of the U.S. Centers for Disease Control and Prevention puts it simply: “There are multiple mechanisms through which Ecstasy can cause death.”
Researchers have learned a great deal about what works in addiction treatment in the last ten years. But many organizations still have trouble translating research into practice -- so-called "technology transfer." 